IN2012DN01234A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01234A IN2012DN01234A IN1234DEN2012A IN2012DN01234A IN 2012DN01234 A IN2012DN01234 A IN 2012DN01234A IN 1234DEN2012 A IN1234DEN2012 A IN 1234DEN2012A IN 2012DN01234 A IN2012DN01234 A IN 2012DN01234A
- Authority
- IN
- India
- Prior art keywords
- compounds
- formula
- well
- pharmaceutically acceptable
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein A, B, R1, R2, R3, R4, R5, n, m and p have the significance given in claim 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09171700 | 2009-09-29 | ||
PCT/EP2010/064217 WO2011039130A1 (en) | 2009-09-29 | 2010-09-27 | New benzimidazole derivatives and their use as fxr agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN01234A true IN2012DN01234A (en) | 2015-05-15 |
Family
ID=43033176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1234DEN2012 IN2012DN01234A (en) | 2009-09-29 | 2010-09-27 |
Country Status (13)
Country | Link |
---|---|
US (1) | US8309581B2 (en) |
EP (1) | EP2483247A1 (en) |
JP (1) | JP5503007B2 (en) |
KR (1) | KR101477872B1 (en) |
CN (1) | CN102574812B (en) |
AU (1) | AU2010303146A1 (en) |
BR (1) | BR112012006986A2 (en) |
CA (1) | CA2772815A1 (en) |
HK (1) | HK1171746A1 (en) |
IL (1) | IL218037A0 (en) |
IN (1) | IN2012DN01234A (en) |
MX (1) | MX2012002479A (en) |
WO (1) | WO2011039130A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT3043865T (en) | 2013-09-11 | 2021-01-14 | Univ Claude Bernard Lyon | Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection |
CN108072684B (en) * | 2016-11-11 | 2020-06-16 | 中国科学院广州生物医药与健康研究院 | Novel ligand of farnesoid X receptor and screening method and application thereof |
BR112019017312A2 (en) | 2017-02-21 | 2020-04-14 | Genfit | combination of a ppar agonist with an fxr agonist |
US20210085662A1 (en) | 2017-03-30 | 2021-03-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for reducing persistence and expression of episomal viruses |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2888847B1 (en) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | N- (HETERIARYL) -1-HETEORARYLALKYL-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION |
JP4970538B2 (en) * | 2006-06-29 | 2012-07-11 | エフ.ホフマン−ラ ロシュ アーゲー | Benzimidazole derivatives, processes for their preparation, their use as FXR agonists and formulations containing them |
DE102007008420A1 (en) | 2007-02-21 | 2008-08-28 | Merck Patent Gmbh | benzimidazole derivatives |
AU2008291148B2 (en) * | 2007-08-27 | 2011-03-17 | F. Hoffmann-La Roche Ag | Benzimidazole derivatives used as FXR agonists |
JP5222953B2 (en) * | 2007-11-15 | 2013-06-26 | エフ.ホフマン−ラ ロシュ アーゲー | Benzimidazole derivatives and their use as FXR agonists |
WO2010028981A1 (en) * | 2008-09-11 | 2010-03-18 | F. Hoffmann-La Roche Ag | New benzimidazole derivatives |
WO2010043513A1 (en) * | 2008-10-15 | 2010-04-22 | F. Hoffmann-La Roche Ag | New benzimidazole derivatives |
-
2010
- 2010-09-20 US US12/885,588 patent/US8309581B2/en not_active Expired - Fee Related
- 2010-09-27 BR BR112012006986A patent/BR112012006986A2/en not_active Application Discontinuation
- 2010-09-27 MX MX2012002479A patent/MX2012002479A/en active IP Right Grant
- 2010-09-27 KR KR1020127010681A patent/KR101477872B1/en not_active IP Right Cessation
- 2010-09-27 CA CA2772815A patent/CA2772815A1/en not_active Abandoned
- 2010-09-27 EP EP10757215A patent/EP2483247A1/en not_active Withdrawn
- 2010-09-27 WO PCT/EP2010/064217 patent/WO2011039130A1/en active Application Filing
- 2010-09-27 JP JP2012531341A patent/JP5503007B2/en not_active Expired - Fee Related
- 2010-09-27 IN IN1234DEN2012 patent/IN2012DN01234A/en unknown
- 2010-09-27 CN CN201080043283.8A patent/CN102574812B/en not_active Expired - Fee Related
- 2010-09-27 AU AU2010303146A patent/AU2010303146A1/en not_active Abandoned
-
2012
- 2012-02-09 IL IL218037A patent/IL218037A0/en unknown
- 2012-12-05 HK HK12112513.9A patent/HK1171746A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX2012002479A (en) | 2012-03-26 |
IL218037A0 (en) | 2012-04-30 |
JP2013505977A (en) | 2013-02-21 |
US8309581B2 (en) | 2012-11-13 |
AU2010303146A1 (en) | 2012-04-19 |
US20110077273A1 (en) | 2011-03-31 |
HK1171746A1 (en) | 2013-04-05 |
CN102574812A (en) | 2012-07-11 |
BR112012006986A2 (en) | 2016-04-12 |
EP2483247A1 (en) | 2012-08-08 |
WO2011039130A1 (en) | 2011-04-07 |
CN102574812B (en) | 2016-03-30 |
JP5503007B2 (en) | 2014-05-28 |
KR101477872B1 (en) | 2014-12-30 |
CA2772815A1 (en) | 2011-04-07 |
KR20120063536A (en) | 2012-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN03337A (en) | ||
MY138941A (en) | Aryl-pyridine derivatives | |
MX2010005824A (en) | Aminothiazole derivatives. | |
MX2011012017A (en) | Azacyclic spiroderivatives as hsl inhibitors. | |
TW200738241A (en) | Pyridazine derivatives | |
IN2012DN01232A (en) | ||
GEP20125487B (en) | Organic compounds and their use | |
TW200745032A (en) | Novel heterobicyclic derivatives | |
TW200626558A (en) | Indazolone derivatives | |
UA108105C2 (en) | Nitrogen-containing heteroaryl compounds | |
TW200616976A (en) | Pyrimidine derivatives | |
MX2009004441A (en) | Indazole derivatives useful as l-cpt1 inhibitors. | |
TW200740764A (en) | Pyrazolone derivatives | |
MX2009010218A (en) | Aza-pyridopyrimidinone derivatives. | |
TW200833324A (en) | Sulfonamide derivatives | |
MX2012007536A (en) | Nitrogen-containing heteroaryl derivatives. | |
UA109037C2 (en) | Triazolepyridins | |
MY139522A (en) | New alkyl-pyridines as 11-beta inhibitors for diabetes | |
IN2012DN00765A (en) | ||
MX2010009022A (en) | 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use. | |
UA102310C2 (en) | Heterocyclic sufonamides, use thereof and pharmaceuticsl compositions | |
MX2010005714A (en) | Pyridine compounds. | |
MX2008016426A (en) | Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1). | |
MX2010001742A (en) | Novel piperazine amide derivatives. | |
GEP201606545B (en) | 2-piperazin-1-yl-4h-1,3-benzo-thiazin-4-one derivatives and their use for treatment of mammalian infections |